Picture of Allogene Therapeutics logo

ALLO Allogene Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Allogene Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments531828457517449
Net Total Accounts Receivable
Net Total Receivables2.42.81.91.81.7
Prepaid Expenses
Total Current Assets545845471529459
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment101160181196163
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets7181,2281,039822643
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities33.194.348.253.737.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities88.8148122155131
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity6291,080916667512
Total Liabilities & Shareholders' Equity7181,2281,039822643
Total Common Shares Outstanding